Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
Condition(s):Cervical CancerLast Updated:November 20, 2013Terminated
Hide Studies Not Open or Pending
Condition(s):Cervical CancerLast Updated:November 20, 2013Terminated
Condition(s):Breast CancerLast Updated:August 16, 2021Unknown status
Condition(s):NSCLCLast Updated:March 17, 2020Completed
Condition(s):Neoplasms, BrainLast Updated:November 24, 2021Completed
Condition(s):Advanced Solid Tumors (Part A/B/C/D); Non-small Cell Lung Cancer (Part E); Melanoma (Part E); Squamous Cell Cancer of the Head and Neck (Part E); Triple Negative Breast Cancer (Part F); Adrenocortical Carcinoma (Part G); Mesothelioma (Part G); High-circulating Myeloid-derived Suppressor Cells (Part H)Last Updated:April 4, 2022Active, not recruiting
Condition(s):Gastric CancerLast Updated:September 24, 2012Terminated
Condition(s):NSCLC Stage IV; ALK Fusion Protein ExpressionLast Updated:January 16, 2024Not yet recruiting
Condition(s):Squamous Cell Esophageal Carcinoma; Esophageal Cancer; Oesophageal CancerLast Updated:January 16, 2024Recruiting
Condition(s):HER-2 Positive Gastric Cancer; Gastrooesophageal Cancer; Esophageal CancerLast Updated:March 14, 2017Withdrawn
Condition(s):Solid Tumor; MelanomaLast Updated:May 6, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.